XMD

controlled modulation of the light that reaches the eyes can have therapeutic effects for numerous diseases. one clinically proven application is the treatment of lazy eye. lazy eye affects up to 5% of all children and can be treated by stimulation of the optic nerve using amblyz™, an fda approved medical device by xmd. xmd, xpand‘s* medical spin off, is using extensive data from clinical trials to develop software and pathways for the establishment of new treatments of other ailments using optic nerve stimulation. we have conducted initial testing, and keep investing in the development of more clinical knowledge. unlike other neurostimulation approaches, xmd works exclusively on stimulation of the optic nerve, by manipulating incoming light rather than using electrical pulses on the spinal and cranial nerves. with this entirely non-invasive method we eliminate the risks and costs involved with surgery needed for implanted neurostimulation devices. our proprietary platform flickset™ is